Report from South Korea - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Report from South Korea
The bio-pharmaceutical business outlook in South Korea remains positive.

Pharmaceutical Technology
Volume 37, Issue 8, pp. 36-37

Moving forward in South Korea
South Korea has sustained rapid growth, low debt, and resilience to global financial stress. South Korea's high-quality healthcare system has stimulated demand for medical tourism with strong government support. Implementation of free-trade agreements with the EU and US will likely have a considerable positive impact on the healthcare market through IP protection, opening of access to the single-payer government system, and a reduction in trade tariffs (estimated to eliminate 95% of tariffs within five years). Overall, the pharmaceutical and biotech business outlook in South Korea remains positive.

On the flip side, manufacturers will need to keep a close eye on reimbursement reform as it progresses, and be prepared to provide both strong clinical and economic data to justify pricing and market access.

1. WHO, Global Health Expenditure Database, World Health Organisation, 2010,, accessed July, 22 2013.
2. Korean Pharmaceutical Traders Association, Korea's Top 10 Exporting Markets, Korean Pharmaceutical Traders Association (2010),
3. Seo, Eunking, Bloomberg BusinessWeek, (21 Feb., 2013),, accessed July, 22 2013.
4. Chung, Seung. Minister's Message. Ministry of Food and Drug Safety, 2013.
5. Kim, So-Hyun, The Korea Herald (Aug. 17, 2011),, accessed 22 July, 2013.
6. Seo, Eun-kyung, Reuters (July 15, 2009),, accessed July 22, 2013.
7. Office of the United States Trade Representative. Press Release (21 Feb., 2012).
8. PhRMA. Press Release, Feb. 21, 2012.
9. Yang BM, Bae EY, Kim J. Health Affairs, (2008) Jan-Feb;27(1):179-87. doi: 10.1377/hlthaff.27.1.179.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here